Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,300
Closed -$394K 4269
2021
Q2
$394K Buy
4,300
+400
+10% +$31.8K ﹤0.01% 3293
2021
Q1
$266K Buy
+3,900
New +$303K ﹤0.01% 3423

Other funds holding CDNA

John Overdeck's CDNA Position: Q2 2026 in Review

John Overdeck increased its CareDx (CDNA) stake by 74% in Q2 2026, buying an estimated $3.71M and bringing the position to 401,987 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #1427.

John Overdeck first reported a position in CDNA in Q4 2017 and has held it in 32 quarters since. The position peaked at $26.6M in Q1 2021. 226 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • John Overdeck held 401,987 shares of CareDx worth $11.5M as of Q2 2026.
  • John Overdeck bought 170,387 CareDx shares in Q2 2026, an estimated $3.71M.
  • CareDx made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1427 holding.
  • John Overdeck first reported a position in CareDx in Q4 2017 and has held it in 32 quarters since.
  • John Overdeck's CareDx position peaked at $26.6M in Q1 2021.
  • 226 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.